Refractory Systemic Lupus Erythematosus Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Refractory Systemic Lupus Erythematosus
Peking University People's Hospital18 enrolled1 locationNCT07617740
Recruiting
Phase 1
Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital12 enrolled1 locationNCT07361094